Stealth Biotheraps Drug Patent Portfolio
Stealth Biotheraps owns 1 orange book drug protected by 6 US patents Given below is the list of Stealth Biotheraps's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11083771 | Methods And Compositions For The Prevention Or Treatment Of Barth Syndrome | 28 Feb, 2034 | Active |
| US11083772 | Methods And Compositions For The Prevention Or Treatment Of Barth Syndrome | 28 Feb, 2034 | Active |
| US11771734 | Methods And Compositions For The Prevention Or Treatment Of Barth Syndrome | 28 Feb, 2034 | Active |
| US12268724 | Methods And Compositions For The Prevention Or Treatment Of Barth Syndrome | 28 Feb, 2034 | Active |
| US9687519 | Methods And Compositions For The Prevention Or Treatment Of Barth Syndrome | 28 Feb, 2034 | Active |
| US7576061 | Methods For Preventing Mitochondrial Permeability Transition | 20 Jan, 2027 | Active |
Latest Legal Activities on Stealth Biotheraps's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Stealth Biotheraps.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Patent Term Extension Application under 35 USC 156 Filed | 14 Nov, 2025 | US7576061 |
| Patent Term Extension Application under 35 USC 156 Filed | 14 Nov, 2025 | US9687519 |
| Patent Term Extension Application under 35 USC 156 Filed | 14 Nov, 2025 | US11771734 |
| Patent Term Extension Application under 35 USC 156 Filed | 14 Nov, 2025 | US11083772 |
| Patent Term Extension Application under 35 USC 156 Filed | 14 Nov, 2025 | US11083771 |
| Email Notification | 09 Apr, 2025 | US12268724 |
| Recordation of Patent Grant Mailed | 08 Apr, 2025 | US12268724 |
| Mail Patent eGrant Notification | 08 Apr, 2025 | US12268724 |
| Patent eGrant Notification | 08 Apr, 2025 | US12268724 |
| Patent Issue Date Used in PTA Calculation | 08 Apr, 2025 | US12268724 |
| Recordation of Patent eGrant | 08 Apr, 2025 | US12268724 |
| Email Notification | 20 Mar, 2025 | US12268724 |
| Issue Notification Mailed | 19 Mar, 2025 | US12268724 |
| Application Is Considered Ready for Issue | 11 Mar, 2025 | US12268724 |
| Dispatch to FDC | 11 Mar, 2025 | US12268724 |
Stealth Biotheraps's Family Patents
Stealth Biotheraps Drug List
Given below is the complete list of Stealth Biotheraps's drugs and the patents protecting them.
1. Forzinity
Forzinity is protected by 6 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11083771 | Methods And Compositions For The Prevention Or Treatment Of Barth Syndrome |
28 Feb, 2034
(7 years from now)
| Active |
| US11083772 | Methods And Compositions For The Prevention Or Treatment Of Barth Syndrome |
28 Feb, 2034
(7 years from now)
| Active |
| US11771734 | Methods And Compositions For The Prevention Or Treatment Of Barth Syndrome |
28 Feb, 2034
(7 years from now)
| Active |
| US12268724 | Methods And Compositions For The Prevention Or Treatment Of Barth Syndrome |
28 Feb, 2034
(7 years from now)
| Active |
| US9687519 | Methods And Compositions For The Prevention Or Treatment Of Barth Syndrome |
28 Feb, 2034
(7 years from now)
| Active |
| US7576061 | Methods For Preventing Mitochondrial Permeability Transition |
20 Jan, 2027
(7 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Forzinity's drug page